Cardiovascular Abnormalities clinical trials

The registry lists 64 studies for Cardiovascular Abnormalities across more than 10 countries. 15 are recruiting or about to start. 31 of them are mainly about Cardiovascular Abnormalities (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 29 narrower conditions too, such as Heart Defects, Congenital: 2,656 studies, 680 open.

Get an email when these change. Save the Cardiovascular Abnormalities studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 31
Recruiting: 10
Status unknown: 7
Terminated: 5
Withdrawn: 4
Not yet recruiting: 4

Phase

Phase 2: 5
Phase 1: 3
Phase 3: 3
Phase 4: 2

Where

United States: 19
France: 8
Canada: 6
China: 6
Brazil: 5
United Kingdom: 4

Who runs them

Peking Union Medical College Hospital (2) · DLR German Aerospace Center (2) · Centre hospitalier de l'Université de Montréal (CHUM) (2) · University of Sao Paulo (2) · University of California, Davis (1) · Erzincan University (1) · Sanifit Therapeutics S. A. (1) · Mayo Clinic (1)

What is being tested here

Drugs under test in Cardiovascular Abnormalities studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Minoxidil	0	0	1
Dobutamine	0	0	1
Mirtazapine	0	0	1
Methamphetamine	0	0	1
Dolutegravir	0	0	1
ISIS 304801	0	0	1
SNF472	0	0	1
B12	0	0	1
Methylprednisolone	0	0	1
Potassium bicarbonate	0	0	1

Coming up

0phase 3 studies under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Dec 2026An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects · Fondation Hôpital Saint-Joseph
Mar 2027Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD · atHeart Medical
Mar 2027Mayo AVC Registry and Biobank · Mayo Clinic
Jun 2027Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System · Shanghai Lingsi Medical Technology Co., Ltd.
Oct 2027Cardiovascular Abnormalities in Children With Attention-deficit/Hyperactivity Disorder · Assiut University

Who these studies take

Of the 10 Cardiovascular Abnormalities studies recruiting now, 7 (70%) set no upper age limit and 1 (10%) stop at 75 or younger. 6 (60%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (30%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	6 (60%)	6 (60%)
18	10 (100%)	10 (100%)
30	10 (100%)	10 (100%)
40	10 (100%)	10 (100%)
50	10 (100%)	10 (100%)
65	10 (100%)	10 (100%)
75	9 (90%)	9 (90%)
85	9 (90%)	9 (90%)

Across all 64 studies, recruiting or not: 27% stop at 75 or younger and 23% at 65; 33% take children; 2% are for women only and 9% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 64. Browse all 64 → or search them.